Published in Biochem J on October 15, 1993
Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J (1995) 2.38
The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol (2012) 1.93
Gene trapping in differentiating cell lines: regulation of the lysosomal protease cathepsin B in skeletal myoblast growth and fusion. J Cell Biol (1996) 0.86
Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice. Am J Pathol (2002) 0.80
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol (1981) 6.84
Inhibitors of lysosomal function. Methods Enzymol (1983) 3.17
Selective control of the degradation of normal and aberrant proteins in Reuber H35 hepatoma cells. Biochem J (1976) 2.87
Nonselective autophagy of cytosolic enzymes by isolated rat hepatocytes. J Cell Biol (1990) 2.84
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet (1992) 1.78
Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer (1975) 1.42
Proteases and proteolysis in the lysosome. Experientia (1992) 1.38
Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem (1989) 1.32
Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis). Biochem J (1991) 1.23
Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem (1987) 1.19
Inhibitors and pathways of hepatocytic protein degradation. Acta Biol Med Ger (1981) 1.14
Both endocytic and endogenous protein degradation in fibroblasts is stimulated by serum/amino acid deprivation and inhibited by 3-methyladenine. Biochem J (1990) 0.94
[Activity determination of proteolytic enzymes using azocasein as a substrate]. Acta Biol Med Ger (1973) 0.89
An abnormality in intracellular protein degradation in fibroblasts from patients with I-cell disease. Clin Chim Acta (1984) 0.80
Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease. Biochem J (1982) 0.80
Collagen degradation in I-cells is normal. Biochem Biophys Res Commun (1990) 0.78
Differentiation of receptor systems activated by sympathomimetic amines. Nature (1967) 11.46
A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature (1991) 7.98
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (1994) 5.34
Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (1994) 3.51
Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med (1983) 2.96
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab (2000) 2.52
CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Neurology (2011) 2.41
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene (1991) 2.21
Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (1999) 2.12
Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet (1999) 2.07
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A (1991) 2.04
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med (1994) 1.97
Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol (1988) 1.93
Cyclin D and oncogenesis. Curr Opin Genet Dev (1993) 1.88
The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase. Proc Natl Acad Sci U S A (1973) 1.86
The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev (1999) 1.78
CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol (1996) 1.72
PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer (1993) 1.70
Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem (1992) 1.66
Ethical issues arising from human genetics. J Med Ethics (1976) 1.65
Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension (1997) 1.59
Interventions for the prevention of nutritional rickets in term born children. Cochrane Database Syst Rev (2007) 1.55
High frequency hearing loss correlated with mutations in the GJB2 gene. Hum Genet (2000) 1.54
Cardiac puncture of fetus with Hurler's disease avoiding abortion of unaffected co-twin. Lancet (1978) 1.52
The Riyadh Intensive Care Program applied to a mortality analysis of a teaching hospital intensive care unit. Anaesthesia (1992) 1.50
I-cell disease: deficiency of extracellular hydrolase phosphorylation. Biochem Biophys Res Commun (1979) 1.46
A -glucuronidase deficiency mucopolysaccharidosis: studies in cultured fibroblasts. Arch Biochem Biophys (1973) 1.45
Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene (1991) 1.44
Cyclins and oncogenesis. Biochim Biophys Acta (1993) 1.41
Treatment of young patients with HNF1A mutations (HNF1A-MODY). Diabet Med (2014) 1.40
Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res (1998) 1.40
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med (1988) 1.39
The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer (1997) 1.35
Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med (1983) 1.32
Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer (1998) 1.30
Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol (1997) 1.29
Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med (1982) 1.29
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency. Humangenetik (1974) 1.26
Further study on the excitation of pyramidal tract cells by intracortical microstimulation. Exp Brain Res (1976) 1.20
Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest (2001) 1.20
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer (2007) 1.20
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol (1995) 1.19
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol (1994) 1.18
Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts. Biochem Biophys Res Commun (1977) 1.18
Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase. Biochem Biophys Res Commun (1974) 1.17
Heterogeneity of erythrocyte catalase. Correlations between sulfhydryl group content, chromatographic and electrophoretic properties. Eur J Biochem (1969) 1.15
An automated continuous assay of membrane-bound and solube ATPases and related enzymes. Anal Biochem (1976) 1.14
Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem (2001) 1.14
Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature. Br J Dermatol (2005) 1.13
Biochemical heterogeneity of the Sanfilippo syndrome: preliminary characterization of two deficient factors. Biochem Biophys Res Commun (1971) 1.12
The Hunter corrective factor. Purification and preliminary characterization. J Biol Chem (1972) 1.11
Ultrasound-guided percutaneous tracheal puncture: a computer-tomographic controlled study in cadavers. Br J Anaesth (2011) 1.11
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene (2009) 1.10
Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res (1994) 1.09
Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res (1998) 1.07
Propionic acidemia: neonatal versus selective metabolic screening. J Inherit Metab Dis (2011) 1.05
Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab (1996) 1.05
Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease. Eur Heart J (1986) 1.04
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer. J Clin Oncol (1990) 1.04
A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest (1997) 1.03
Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther (2007) 1.02
Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab (2000) 1.02
The beta-2 receptor mediated glycogenolytic responses to catecholamines in the dog. Arch Int Pharmacodyn Ther (1968) 1.02
Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab (1998) 1.02
Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res (1996) 1.02
Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. J Clin Endocrinol Metab (2000) 1.01
Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem (1998) 1.01
Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer. Patient Educ Couns (1999) 1.01
Follow-up of "non-diabetic" relatives of diabetics by retesting oral glucose tolerance after 5 years. Diabetologia (1975) 1.00
Ontogeny of androgen receptor immunoreactivity in lumbar motoneurons and in the sexually dimorphic levator ani muscle of male rats. J Comp Neurol (1997) 0.99
Differentiation of receptors activated by catecholamines. 3. Farmaco Sci (1972) 0.98
The mucopolysaccharidoses: inborn errors of glycosaminoglycan catabolism. Hum Genet (1976) 0.97
Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol (1995) 0.97
Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J (2001) 0.96
Adult alpha-mannosidosis: clinical progression in the absence of demyelination. Neurology (2004) 0.96
p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab (1994) 0.96
Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem (1995) 0.95
The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug. Atherosclerosis (1979) 0.95
A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. Int J Cancer (1998) 0.95
Sandhoff disease: defective glycosaminoglycan catabolism in cultured fibroblasts and its correction by beta-N-acetylhexosaminidase. Eur J Biochem (1974) 0.95
Phosphorylation of lysosomal enzymes in fibroblasts. Marked deficiency of N-acetylglucosamine-1-phosphotransferase in fibroblasts of patients with mucolipidosis III. Hoppe Seylers Z Physiol Chem (1982) 0.94
Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med (1990) 0.94
The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev (2007) 0.94
Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation. Int J Cancer (1999) 0.94